The Effect of Propolis Administration on Cholesterol Level in Diabetic Type 2 Patients
The goal of this clinical trial is to learn if propolis administration works to change the level of Low Density Lipoprotein (LDL) and High Density Lipoprotein cholesterol (HDL) in diabetic type 2 patients. The main questions it aims to answer are: \- Is giving 1 drops/ 10kg/ times, twice daily for 8 weeks will change the level of LDL and HDL level in diabetic type 2 patients compared to placebo? Researchers will compare propolis to a placebo (a look-alike substance that contains no drug) to see if propolis works…
Conditions studied
Diabetes Mellitus Type 2
About this study
The goal of this clinical trial is to learn if propolis administration works to change the level of Low Density Lipoprotein (LDL) and High Density Lipoprotein cholesterol (HDL) in diabetic type 2 patients. The main questions it aims to answer are: \- Is giving 1 drops/ 10kg/ times, twice daily for 8 weeks will change the level of LDL and HDL level in diabetic type 2 patients compared to placebo? Researchers will compare propolis to a placebo (a look-alike substance that contains no drug) to see if propolis works to change LDL and HDL cholesterol level. Participants will: * Take propolis or a placebo, 2 times daily with given dose (1 drops/10 kg/times) every day for 2 months * Visit the sub-district health centre once every 2 weeks for checkups * Get their blood checked before and after intervention
Interventions
- Drug: Propolis drops — The intervention given is propolis drops that are approved by Indonesian Food and Drug Authority
- Other: Placebo — The given placebo are look-alike substance with no effect
Primary outcomes
- Low Density Lipoprotein (8 weeks)
- High Density Lipoprotein (8 weeks)
Eligibility information
Study locations
- University of Indonesia Faculty of Biomedical Science, Jakarta, 10430 Indonesia
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.